Drug intelligence / Profile preview

camazepam

Development stage
Unknown
Lead developer
Siphar
Modality
Small Molecules
Administration
Oral
01

Overview

Camazepam is a benzodiazepine psychoactive drug primarily indicated for the short-term treatment of insomnia and anxiety. It is a dimethyl carbamate ester of temazepam, itself a metabolite of diazepam. Camazepam acts as a positive allosteric modulator at the benzodiazepine binding site on the Gamma-aminobutyric acid type A receptor (GABA(A) receptor), enhancing the inhibitory effects of GABA in the central nervous system. Compared to other benzodiazepines, it has reduced side effects such as impaired cognition and motor coordination, making it particularly suitable as an anxiolytic. Its anxiolytic properties are more prominent than its anticonvulsant, hypnotic, or muscle relaxant effects. Camazepam is almost completely absorbed after oral administration and is metabolized into active metabolites including temazepam and oxazepam.

Brand names
AlbegoLimpidonPaxor
Other names
camazepam [INN]
02

Targets

GABAA (Gamma-aminobutyric acid receptor)

Beyond the preview

Go deeper on camazepam.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on camazepam.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call